Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nrf2 as a potential target for Parkinson’s disease therapy
Yingcai Niu, Jing Zhang, Miaoxian Dong
Journal of Molecular Medicine (2021) Vol. 99, Iss. 7, pp. 917-931
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Nrf2/Keap1/ARE signaling: Towards specific regulation
A. V. Ulasov, Andrey A. Rosenkranz, Georgii P. Georgiev, et al.
Life Sciences (2021) Vol. 291, pp. 120111-120111
Open Access | Times Cited: 319
Mitochondrial dysfunction in neurodegenerative disorders
Madelyn Klemmensen, Seth H. Borrowman, Colin Pearce, et al.
Neurotherapeutics (2023) Vol. 21, Iss. 1, pp. e00292-e00292
Open Access | Times Cited: 69
Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential
Xv-shen Ding, Li Gao, Han Zheng, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102077-102077
Closed Access | Times Cited: 63
The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease
Amritha Chakkittukandiyil, Deepak Vasudevan Sajini, Arjunan Karuppaiah, et al.
Neurochemistry International (2022) Vol. 156, pp. 105325-105325
Closed Access | Times Cited: 46
Role of Nrf2 in Parkinson’s Disease: Toward New Perspectives
Xin-xing Yang, Rong Yang, Feng Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis
Xiaoying Jiang, Kaiyu Wu, Xiang‐Yang Ye, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 872-896
Closed Access | Times Cited: 30
Neuroprotective potential of Moringa oleifera mediated by NF‐kB/Nrf2/HO‐1 signaling pathway: A review
Maroti Mundkar, Anjali Bijalwan, Divya Soni, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Open Access | Times Cited: 28
NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
Juan A. Parga, Ana I. Rodríguez‐Pérez, María García-Garrote, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1649-1649
Open Access | Times Cited: 34
Protective Effects of Querectin against MPP+-Induced Dopaminergic Neurons Injury via the Nrf2 Signaling Pathway
Yanyan Jiang, Guangming Xie, Aydos Alimujiang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 3, pp. 42-42
Open Access | Times Cited: 15
Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations
Pranshul Sethi, Sidharth Mehan, Zuber Khan, et al.
NeuroToxicology (2023) Vol. 98, pp. 61-85
Open Access | Times Cited: 14
α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson’s disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway
Bingxu Huang, Guiqiu Hu, Xiaofeng Zong, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109698-109698
Closed Access | Times Cited: 13
Modulating SQSTM1/p62-dependent selective autophagy of neurons by activating Nrf2 with multifunctional nanoparticles to eliminate α-synuclein aggregates and boost therapy of Parkinson’s disease
Hanghang Liu, Qing Yin Zheng, Jiaxin Yuan, et al.
Nano Today (2023) Vol. 49, pp. 101770-101770
Closed Access | Times Cited: 12
Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
Brigitta Buttari, Antonella Tramutola, Ana I. Rojo, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 113-113
Open Access
Emodin, a Potent Anthraquinone Mitigates MPTP-Induced Parkinsons’ Disease Pathology by Regulating Nrf2 and Its Downstream Targets: In Silico and In Vivo Approach
Sarwat Jahan, Muhammad Ikram, Sami Siraj, et al.
Molecular Neurobiology (2025)
Closed Access
Generation and characterisation of seven induced pluripotent stem cell lines from two patients with Parkinson’s disease carrying the pathological variant c.1087G>T of the LGR4 gene
V. S. Podvysotskaya, Е. В. Григорьева, Anastasia A. Malakhova, et al.
Vavilov Journal of Genetics and Breeding (2025) Vol. 29, Iss. 1, pp. 15-25
Open Access
Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson’s Disease
Matthew K. Boag, Angus Roberts, Vladimir N. Uversky, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2378-2378
Open Access | Times Cited: 17
Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease
Michał Rakowski, Szymon Porębski, Agnieszka Grzelak
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3625-3625
Open Access | Times Cited: 16
Antioxidant Therapy as an Effective Strategy against Noise-Induced Hearing Loss: From Experimental Models to Clinic
Anna Pisani, Fabiola Paciello, Raffaele Montuoro, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1035-1035
Open Access | Times Cited: 10
Overview on the Polyphenol Avenanthramide in Oats (Avena sativa Linn.) as Regulators of PI3K Signaling in the Management of Neurodegenerative Diseases
Nitu L. Wankhede, Mayur B. Kale, Ashwini K. Bawankule, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3751-3751
Open Access | Times Cited: 9
Tetramethylpyrazine nitrone exerts neuroprotection via activation of PGC-1α/Nrf2 pathway in Parkinson’s disease models
Baojian Guo, Chengyou Zheng, Jie Cao, et al.
Journal of Advanced Research (2023) Vol. 64, pp. 195-211
Open Access | Times Cited: 8
Mechanism of Gastrodin against neurotoxicity based on network pharmacology, molecular docking and experimental verification
Han Guo, Chenyang Li, Jiaojiao Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117611-117611
Open Access | Times Cited: 2
Inhibition of the TLR/NF-κB Signaling Pathway and Improvement of Autophagy Mediates Neuroprotective Effects of Plumbagin in Parkinson’s Disease
Yan Su, Li Mao, Qi Wang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 12
Vitexin and isovitexin delayed ageing and enhanced stress-resistance through the activation of the SKN-1/Nrf2 signaling pathway
Mingfang Tao, Rong Li, Tingting Xu, et al.
International Journal of Food Sciences and Nutrition (2023) Vol. 74, Iss. 6, pp. 685-694
Open Access | Times Cited: 4
Nrf2 Deficiency Exacerbates Parkinson’s Disease by Aggravating NLRP3 Inflammasome Activation in MPTP-Induced Mouse Models and LPS-Induced BV2 Cells
Ranran Lu, Xu Zhou, Lijie Zhang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6277-6295
Open Access | Times Cited: 1
CBR-470-1 protects against cardiomyocyte death in ischaemia/reperfusion injury by activating the Nrf2–GPX4 cascade
Zeyang Qiu, Kai-Na Shi, Hui‐Hua Li, et al.
Toxicology and Applied Pharmacology (2024) Vol. 492, pp. 117113-117113
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top